Article info

Download PDFPDF

Original article
Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database

Authors

  • Oluwaseun Egunsola Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Derby, UK PubMed articlesGoogle scholar articles
  • Kristina Star Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Kristina Juhlin Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Sylvia H Kardaun Department of Dermatology, Reference Center for Cutaneous Adverse Reactions, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Imti Choonara Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Derby, UK PubMed articlesGoogle scholar articles
  • Helen M Sammons Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Derby, UK North Devon District Hospital, Raleigh Park, Barnstaple, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Oluwaseun Egunsola; seunegunsola{at}yahoo.com
View Full Text

Citation

Egunsola O, Star K, Juhlin K, et al
Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database

Publication history

  • Received April 14, 2017
  • Revised June 15, 2017
  • Accepted June 16, 2017
  • First published August 4, 2017.
Online issue publication 
August 04, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.